Position in ALKS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,791,190
+$2,204,624 QoQ
Shares Held
53,267
+199.9% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#150
of 421 holders
Holding Since
Sep 2021
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Baird Financial Group, Inc. holds $29,735,464 across 12 Drug Manufacturers - Specialty & Generic names. ALKS ranks #4 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
131,829 | $9,473,231 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
39,868 | $6,719,350 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
29,356 | $3,256,753 | |
| 4 | ALKS |
Alkermes plc.
This page
|
53,267 | $2,791,190 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
65,575 | $2,273,484 | |
| 6 | VTRS |
Viatris Inc
|
130,001 | $2,064,415 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
30,708 | $1,963,776 | |
| 8 | PAHC |
Phibro Animal Health Corp
|
10,710 | $336,293 |
All Filings in ALKS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,791,190 | 53,267 | Shares | Defined | 2026-08-12 | |
| 2025-03-31 | $586,566 | 17,764 | Shares | Defined | 2025-05-15 | |
| 2021-09-30 | $466,054 | 15,112 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||